Abstract:Leukocytosis in association with malignancies was first described more than 30 years ago and colony stimulating factors (CSF), which stimulate colony formation of granulocytehacrophage progenitor cells in vitro, have been implicated in the regulation of granulopoiesis. Since the first report of the establishment of a CSF producing cancer cell line (l), which secreted CSF and induced marked leukocytosis in transplanted nude mice, several CSF producing cell lines have been established from various types of tumors. We report here the establishment of a new cell line secreting both granulocyt colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GMCSF) from a patient with large cell carinoma of the lung. Case report: A 40-yr-old female was admitted to Kyushu University Hospital because of headache and left hemiparesis. Chest roentgenogram revealed a nodule in the left upper lung field and cerebral metastasis with marked edema was confirmed. WBC counts were increased to 80.2 x IO9A with 34% bands, 59% segmented, 5% monocytes and 2% lymphocytes, without evidence of infection. Tumor cells were obtained from the biopsied metastatic lymph node and cultured for the establishment of a cells line. After 40 passages in Isove’s modified Dulbecco’s medium supplemented with 10% fetal calf serum, a cell line, named SMAT, was established. Supernatants from the cell line were assayed for the evaluation of CSF activity and in vitro methylcellulose colony forming assay of human bone marrow nonadherent cells. Colonies derived from granulocyte colony forming cells (G-CFC) and granulocyte-macrophage colony forming cells (GM-CSF) were counted after incubation for 7 and 14 days, respectively, and the number of colonies was expressed as a CSF activity. When different concentrations of supernatants were added, G-CFC and GM-CFC derived colonies were formed in a dose-dependent manner and reached plateau levels with 10% of the supernatant. Chromosome analysis of the cells revealed complicated abnormalities with marker chromosomes including 3qt, l lqt , and some unknown. Significant abnormalities were not observed in 5q and 17q, in which the GMand G-CSF genes are located, respectively. Northern blot analyses Figure I . Expression of GM-CSF mRNA (A) and G-CSF mRNA (B) in the cell lines.

Chemistry42: an AI-Driven Platform for Molecular Design and Optimization.

Chemistry42: An AI-based platform for de novo molecular design

The AI-driven Drug Design (AIDD) platform: an interactive multi-parameter optimization system integrating molecular evolution with physiologically based pharmacokinetic simulations

Application scenario-oriented molecule generation platform developed for drug discovery

The Process of AI-Aided Drug Design

Impact of Artificial Intelligence on Compound Discovery, Design, and Synthesis

AI-driven drug discovery: identification and optimization of ALDH3A1 selective inhibitors with nanomolar activity

Guided Multi-objective Generative AI to Enhance Structure-based Drug Design

AI-chemist for Chemistry Synthesis, Property Characterization, and Performance Testing

Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an in vitro study

ChemMORT: an automatic ADMET optimization platform using deep learning and multi-objective particle swarm optimization

SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability

Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science

ChemPrint: An AI-Driven Framework for Enhanced Drug Discovery

Artificial Intelligence for Autonomous Molecular Design: A Perspective

DrugFlow: an AI-Driven One-Stop Platform for Innovative Drug Discovery.

Hit Identification Driven by Combining Artificial Intelligence and Computational Chemistry Methods: A PI5P4K-β Case Study

MolDesigner: Interactive Design of Efficacious Drugs with Deep Learning

ESTABLISHMENT OF A G‐CSF AND GM‐CSF PRODUCING CELL LINE FROM HUMAN LARGE CELL CARCINOMA OF THE LUNG

Tartarus: A Benchmarking Platform for Realistic And Practical Inverse Molecular Design

An Artificial Intelligence Framework for Optimal Drug Design